


As the demand for semaglutide soars, fueled by stories of rapid results, the market is adjusting to meet demand. This gives rise to new compounded, off-brand versions of popular drugs like Ozempic and Wegovy. This article will help explain the current, complex landscape of semaglutide options, comparing FDA-approved options with the risks associated with unofficial versions flooding the market — and your social media platforms. Here’s what you need to know to stay informed.